Biocon inks license, supply pact with CMS for 3 generic formulations Medical Dialogues Bureau13 Sep 2019 9:15 AM GMTUnder the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab Medical Dialogues Bureau28 Jun 2019 7:00 AM GMTThe initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...